| pubmed-article:19167587 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0042960 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0024554 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0152035 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C1549078 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0150097 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C1997894 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0039225 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0289313 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0795660 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0039789 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0524527 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C0871161 | lld:lifeskim |
| pubmed-article:19167587 | lifeskim:mentions | umls-concept:C1512523 | lld:lifeskim |
| pubmed-article:19167587 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:19167587 | pubmed:dateCreated | 2009-1-26 | lld:pubmed |
| pubmed-article:19167587 | pubmed:abstractText | Rosiglitazone is an insulin-sensitizing oral thiazolidinedione used for treating patients with type 2 diabetes mellitus. There are 9 oral generic and branded formulations of rosiglitazone available in the People's Republic of China (PRC); however, a literature search did not identify any published data concerning the bioavailability of these formulations in the Chinese population. | lld:pubmed |
| pubmed-article:19167587 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19167587 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19167587 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19167587 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19167587 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19167587 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19167587 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19167587 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19167587 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19167587 | pubmed:issn | 0149-2918 | lld:pubmed |
| pubmed-article:19167587 | pubmed:author | pubmed-author:UrenCC | lld:pubmed |
| pubmed-article:19167587 | pubmed:author | pubmed-author:HEUI MIM | lld:pubmed |
| pubmed-article:19167587 | pubmed:author | pubmed-author:DuL CLC | lld:pubmed |
| pubmed-article:19167587 | pubmed:author | pubmed-author:HeL-MLM | lld:pubmed |
| pubmed-article:19167587 | pubmed:author | pubmed-author:QiJinwenJ | lld:pubmed |
| pubmed-article:19167587 | pubmed:author | pubmed-author:FangShunganS | lld:pubmed |
| pubmed-article:19167587 | pubmed:author | pubmed-author:LiGonghuaG | lld:pubmed |
| pubmed-article:19167587 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19167587 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:19167587 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19167587 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19167587 | pubmed:pagination | 2272-9 | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:meshHeading | pubmed-meshheading:19167587... | lld:pubmed |
| pubmed-article:19167587 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:19167587 | pubmed:articleTitle | Bioequivalence and comparison of pharmacokinetic properties of 4-mg tablet formulations of rosiglitazone hydrochloride and rosiglitazone maleate: a single-dose, randomized, open-label, two-period crossover study in healthy adult male Chinese volunteers. | lld:pubmed |
| pubmed-article:19167587 | pubmed:affiliation | Department of Clinical Pharmacology, Zhejiang Provincial People's Hospital, Hangzhou, People's Republic of China. | lld:pubmed |
| pubmed-article:19167587 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19167587 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19167587 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19167587 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
